Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Avadel Pharmaceuticals plc (AVDL) Message Board

Latest Flamel Technologies S.A. (FLML) Headlines

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 92
Posted On: 03/13/2014 8:36:08 AM
Avatar
Posted By: Stock_Tracker
Latest Flamel Technologies S.A. (FLML) Headlines

Flamel Technologies prices public offering at USD9.75 per ADS
M2 - Mon Mar 10, 4:12AM CDT
Drug delivery company Flamel Technologies (NASDAQ:FLML) said on Friday that it has priced its offering of American Depositary Shares (ADSs), representing 10,800,000 ordinary shares.

Flamel Technologies, S.A. Announces Pricing of Public Offering of American Depositary Shares
Marketwire - Fri Mar 07, 7:39AM CST
Flamel Technologies, S.A. (NASDAQ: FLML) today announced the pricing of an underwritten offering of American Depositary Shares (ADSs), representing 10,800,000 ordinary shares, at a price to the public of $9.75 per ADS. All of the ADSs in this offering are to be sold by Flamel. Flamel has granted the underwriters a 30-day option to purchase up to an additional 1,600,000 ADSs to cover over-allotments, if any, in connection with the offering. The offering is expected to close on March 12, 2014, subject to customary closing conditions.

Flamel Technologies plans to issue ADSs in public offering
M2 - Fri Mar 07, 6:02AM CST
Drug delivery company Flamel Technologies SA (NASDAQ:FLML) said on Thursday that it intends to sell American Depositary Shares (ADSs), representing its ordinary shares, in an underwritten public offering.

Flamel Technologies, S.A. Announces Proposed Underwritten Public Offering of American Depositary Shares
Marketwire - Thu Mar 06, 3:01PM CST
Flamel Technologies, S.A. (NASDAQ: FLML) today announced that it is offering to sell American Depositary Shares (ADSs), representing its ordinary shares, in an underwritten public offering. In connection with the offering, Flamel intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs offered in the public offering to cover over-allotments, if any.

Flamel Technologies Up 57.5% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Fri Jan 17, 4:43PM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 2 months, Flamel Technologies has returned 57.54% as of today's recent price of $10.61.

Flamel Technologies (FLML) in Focus: Stock Jumps 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 13, 7:37AM CST
Flamel Technologies SA was a big mover last session, as the company saw its shares rise almost 9% on the day.

Flamel Technologies Up 48.3% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Fri Jan 10, 10:59AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 2 months, Flamel Technologies has returned 48.33% as of today's recent price of $9.99.

New IGP Sets His Priorities, Warns Unethical Officers
by Abdulwakil Saiboko - All Africa Global Media - Thu Jan 09, 10:36PM CST
THE newly-appointed Inspector- General of Police (IGP), Mr Ernest Mangu, has outlined his priorities, warning police over unethical behaviour, saying severe measures will be taken against violators.

Flamel Technologies SA (FLML) Jumps: Stock Adds 8.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 8:39AM CST
Flamel Technologies SA was a big mover last session, as its shares rose almost 9% on the day.

Flamel Technologies Shares Up 22.0% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Fri Jan 03, 9:52AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 2 months, Flamel Technologies has returned 22.05% as of today's recent price of $8.22.

Flamel Technologies Shares Up 19.2% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Fri Dec 27, 9:25AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 1 month, Flamel Technologies has returned 19.23% as of today's recent price of $8.03.

16.6% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Thu Dec 19, 9:54AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 1 month, Flamel Technologies has returned 16.62% as of today's recent price of $7.85.

Flamel Technologies enters into USD15m line of credit with Broadfin Capital
M2 - Thu Dec 05, 10:33AM CST
Drug delivery company Flamel Technologies (NASDAQ:FLML) reported on Wednesday the execution of a USD15.0m secured line of credit with Broadfin Capital, its current shareholder.

Flamel Technologies Announces $15 Million Line of Credit
Marketwire - Wed Dec 04, 3:05PM CST
Flamel Technologies (NASDAQ: FLML) today announced that it established a USD $15.0 million secured line of credit with Broadfin Capital, a current Flamel shareholder. The $15.0 million credit facility can be drawn in three tranches of $5.0 million each. The Company will draw $5.0 million initially and can draw up to two additional $5.0 million tranches prior to August 15, 2014, subject to satisfaction of funding conditions. This line of credit financing will allow the Company to continue its investment in R&D projects and the launch of its first-NDA approved product, Bloxiverz(TM). The interest rate on any outstanding loan is 12.5% and the loan must be repaid on or before November 15, 2015. There is no cost for undrawn capital or any penalty or premium for early repayment. For each tranche of the line of credit drawn by Flamel, Broadfin Capital will also receive a royalty of less than 1.0% (subject to a maximum cumulative royalty of 2.0% if all three tranches are drawn) on net sales of Bloxiverz and the other products resulting from the R&D projects of the former Eclat Pharmaceuticals, subject to required regulatory approvals and sales of these products.

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 12, 5:19PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Flamel Technologies Announces Third Quarter 2013 Results
Marketwire - Thu Oct 31, 6:30AM CDT
Flamel Technologies (NASDAQ: FLML) today announced its financial results for the third quarter of 2013. Highlights from the quarter include:

Uptrend Call Working As Flamel Technologies Stock Rises 19.9% (FLML)
Comtex SmarTrend(R) - Wed Oct 30, 4:58PM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 3rd, 2013 at $5.54. In approximately 5 months, Flamel Technologies has returned 19.86% as of today's recent price of $6.64.

24.9% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Wed Oct 23, 11:05AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 3rd, 2013 at $5.54. In approximately 5 months, Flamel Technologies has returned 24.91% as of today's recent price of $6.92.

Flamel Technologies Announces Projected Release Date of Third Quarter 2013 Results and Conference Call
Marketwire - Thu Oct 17, 6:01AM CDT
Flamel Technologies (NASDAQ: FLML) expects to release certain financial results for the third quarter of 2013 on Thursday, October 31, 2013, before the market open. A conference call to discuss these results has been scheduled for Thursday, October 31st at 10:00 AM (Eastern Daylight Time). A question and answer period will follow management's prepared remarks.


(0)
(0)




Avadel Pharmaceuticals plc (AVDL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us